SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-361760
Filing Date
2021-12-20
Accepted
2021-12-20 08:00:33
Documents
12
Period of Report
2021-12-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d274235d8k.htm   iXBRL 8-K 21453
  Complete submission text file 0001193125-21-361760.txt   138612

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA crsp-20211214.xsd EX-101.SCH 2892
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE crsp-20211214_lab.xml EX-101.LAB 17306
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crsp-20211214_pre.xml EX-101.PRE 10929
6 EXTRACTED XBRL INSTANCE DOCUMENT d274235d8k_htm.xml XML 3268
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37923 | Film No.: 211503685
SIC: 2836 Biological Products, (No Diagnostic Substances)